Skip to content

Entecavir

Baraclude (entecavir) is a small molecule pharmaceutical. Entecavir was first approved as Baraclude on 2005-03-29. It is used to treat chronic hepatitis b and hepatitis b in the USA. It has been approved in Europe to treat chronic hepatitis b and hepatitis b.
Trade Name Baraclude
Common Name Entecavir
Indication chronic hepatitis b, hepatitis b
Drug Class Antivirals: carbocyclic nucleosides
Entecavir
Get full access now